1.
David E. Spaner, Guizhei Wang, Lindsay McCaw, Yanmei Li, Patricia Disperati, Mary-Ann Cussen, Yonghong Shi. Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial. haematol [Internet]. 2016May1 [cited 2021Jan.26];101(5):e192-e195. Available from: https://haematologica.org/article/view/7721